These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 38238158)
1. Artificial intelligence-based analysis of tumor-infiltrating lymphocyte spatial distribution for colorectal cancer prognosis. Cai M; Zhao K; Wu L; Huang Y; Zhao M; Hu Q; Chen Q; Yao S; Li Z; Fan X; Liu Z Chin Med J (Engl); 2024 Feb; 137(4):421-430. PubMed ID: 38238158 [TBL] [Abstract][Full Text] [Related]
2. An artificial intelligence-based ecological index for prognostic evaluation of colorectal cancer. Chen Q; Cai M; Fan X; Liu W; Fang G; Yao S; Xu Y; Li Q; Zhao Y; Zhao K; Liu Z; Chen Z BMC Cancer; 2023 Aug; 23(1):763. PubMed ID: 37592224 [TBL] [Abstract][Full Text] [Related]
3. Immunoscore encompassing CD3+ and CD8+ T cell densities in distant metastasis is a robust prognostic marker for advanced colorectal cancer. Kwak Y; Koh J; Kim DW; Kang SB; Kim WH; Lee HS Oncotarget; 2016 Dec; 7(49):81778-81790. PubMed ID: 27835889 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of CD3 and CD8 T-Cell Immunohistochemistry for Prognostication and Prediction of Benefit From Adjuvant Chemotherapy in Early-Stage Colorectal Cancer Within the QUASAR Trial. Williams CJM; Gray R; Hills RK; Shires M; Zhang L; Zhao Z; Gardner T; Sapanara N; Xu XM; Bai I; Yan D; Muranyi A; Dance S; Aghaei F; Hemmings G; Hale M; Kurkure U; Guetter C; Richman SD; Hutchins G; Seligmann JF; West NP; Singh S; Shanmugam K; Quirke P J Clin Oncol; 2024 Oct; 42(29):3430-3442. PubMed ID: 39083705 [TBL] [Abstract][Full Text] [Related]
5. Development of a Fully Automated Method to Obtain Reproducible Lymphocyte Counts in Patients With Colorectal Cancer. Fiehn AK; Reiss B; Gögenur M; Bzorek M; Gögenur I Appl Immunohistochem Mol Morphol; 2022 Aug; 30(7):493-500. PubMed ID: 35703148 [TBL] [Abstract][Full Text] [Related]
6. Automated Analysis of Lymphocytic Infiltration, Tumor Budding, and Their Spatial Relationship Improves Prognostic Accuracy in Colorectal Cancer. Nearchou IP; Lillard K; Gavriel CG; Ueno H; Harrison DJ; Caie PD Cancer Immunol Res; 2019 Apr; 7(4):609-620. PubMed ID: 30846441 [TBL] [Abstract][Full Text] [Related]
7. Artificial intelligence-assisted analysis for tumor-immune interaction within the invasive margin of colorectal cancer. Ye Y; Wu X; Wang H; Ye H; Zhao K; Yao S; Liu Z; Zhu Y; Zhang Q; Liang C Ann Med; 2023 Dec; 55(1):2215541. PubMed ID: 37224471 [TBL] [Abstract][Full Text] [Related]
8. Loss of survival advantage for deficient mismatch repair in patients with advanced colorectal cancer may be caused by changes in prognostic value of CD8+T cell. Wang B; Li F; Guo L; Lu S; Ma J; Ma Y; Meng Y; Wang J; Zhou X; Fu W World J Surg Oncol; 2020 Aug; 18(1):196. PubMed ID: 32767974 [TBL] [Abstract][Full Text] [Related]
9. The Determination of Immunomodulation and Its Impact on Survival of Rectal Cancer Patients Depends on the Area Comprising a Tissue Microarray. Gruber ES; Oberhuber G; Pils D; Stork T; Sinn K; Gruber S; Nica R; Kolmer D; Turner SD; Schlederer M; Widder J; Doerr W; Teleky B; Kenner L Cancers (Basel); 2020 Feb; 12(3):. PubMed ID: 32121328 [TBL] [Abstract][Full Text] [Related]
10. Differential gene expression of tumor-infiltrating CD8 Saleh R; Sasidharan Nair V; Toor SM; Taha RZ; Murshed K; Al-Dhaheri M; Khawar M; Petkar MA; Abu Nada M; Al-Ejeh F; Elkord E J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32948653 [TBL] [Abstract][Full Text] [Related]
11. Intertumoral Heterogeneity of CD3 Yoon HH; Shi Q; Heying EN; Muranyi A; Bredno J; Ough F; Djalilvand A; Clements J; Bowermaster R; Liu WW; Barnes M; Alberts SR; Shanmugam K; Sinicrope FA Clin Cancer Res; 2019 Jan; 25(1):125-133. PubMed ID: 30301825 [TBL] [Abstract][Full Text] [Related]
12. Clinical Significance of a CD3/CD8-Based Immunoscore in Neuroblastoma Patients Using Digital Pathology. Zeng L; Li SH; Xu SY; Chen K; Qin LJ; Liu XY; Wang F; Fu S; Deng L; Wang FH; Miao L; Li L; Liu N; Wang R; Wang HY Front Immunol; 2022; 13():878457. PubMed ID: 35619699 [TBL] [Abstract][Full Text] [Related]
13. Clinical impact of heterogeneously distributed tumor-infiltrating lymphocytes on the prognosis of colorectal cancer. Liu L; Long M; Su S; Wang L; Liu J PeerJ; 2024; 12():e16747. PubMed ID: 38223758 [TBL] [Abstract][Full Text] [Related]
14. The prognostic value of tumor-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: a systematic review and meta-analysis. Zhao Y; Ge X; He J; Cheng Y; Wang Z; Wang J; Sun L World J Surg Oncol; 2019 May; 17(1):85. PubMed ID: 31118034 [TBL] [Abstract][Full Text] [Related]
15. Density and location of CD3 Zhou C; Wu Y; Jiang L; Li Z; Diao P; Wang D; Zhang W; Liu L; Wang Y; Jiang H; Cheng J; Yang J J Oral Pathol Med; 2018 Apr; 47(4):359-367. PubMed ID: 29469989 [TBL] [Abstract][Full Text] [Related]
16. A deep learning quantified stroma-immune score to predict survival of patients with stage II-III colorectal cancer. Xu Z; Li Y; Wang Y; Zhang S; Huang Y; Yao S; Han C; Pan X; Shi Z; Mao Y; Xu Y; Huang X; Lin H; Chen X; Liang C; Li Z; Zhao K; Zhang Q; Liu Z Cancer Cell Int; 2021 Oct; 21(1):585. PubMed ID: 34717647 [TBL] [Abstract][Full Text] [Related]
17. Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer. Schweiger T; Berghoff AS; Glogner C; Glueck O; Rajky O; Traxler D; Birner P; Preusser M; Klepetko W; Hoetzenecker K Clin Exp Metastasis; 2016 Oct; 33(7):727-39. PubMed ID: 27449756 [TBL] [Abstract][Full Text] [Related]
18. Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer. Kuwahara T; Hazama S; Suzuki N; Yoshida S; Tomochika S; Nakagami Y; Matsui H; Shindo Y; Kanekiyo S; Tokumitsu Y; Iida M; Tsunedomi R; Takeda S; Yoshino S; Okayama N; Suehiro Y; Yamasaki T; Fujita T; Kawakami Y; Ueno T; Nagano H Br J Cancer; 2019 Oct; 121(8):659-665. PubMed ID: 31488881 [TBL] [Abstract][Full Text] [Related]
19. Tumor-associated CD3- and CD8-positive immune cells in colorectal cancer: The additional prognostic value of CD8+-to-CD3+ ratio remains debatable. Kasurinen J; Hagström J; Kaprio T; Beilmann-Lehtonen I; Haglund C; Böckelman C Tumour Biol; 2022; 44(1):37-52. PubMed ID: 35404299 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the prognostic value of stromal tumor-infiltrating lymphocytes and CD3 + T cells between schistosomal and non-schistosomal colorectal cancer. Wang W; Zhang Y; Liu J; Jing H; Lu K; Wang L; Zhu T; Xu Y; Bu D; Cheng M; Liu J; Shen W; Yao J; Huang S World J Surg Oncol; 2023 Feb; 21(1):31. PubMed ID: 36726115 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]